About Akonni
Akonni is a company based in Frederick (United States) founded in 2003. Akonni has raised $39.75 million across 50 funding rounds from investors including NIH, HHS and Ojp. The company has 12 employees as of December 31, 2022. Akonni offers products and services including TruTip Nucleic Acid Universal Kit, TruPrepR Automated Sample Preparation System, and TruDiagnosis. Akonni operates in a competitive market with competitors including Somalogic, Nautilus Biotechnology, Inflammatix, Amunix and Visby Medical, among others.
- Headquarter Frederick, United States
- Employees 12 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Akonni Biosystems, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$39.75 M (USD)
in 50 rounds
-
Latest Funding Round
$168.09 K (USD), Grant
Sep 20, 2021
-
Investors
NIH
& 5 more
-
Employee Count
12
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Akonni
Akonni offers a comprehensive portfolio of products and services, including TruTip Nucleic Acid Universal Kit, TruPrepR Automated Sample Preparation System, and TruDiagnosis.
Robust technology for high-yield DNA and RNA extraction.
System providing higher purity for nucleic acid processing.
Integrated system for rapid multiplexed disease analysis.
People of Akonni
Unlock access to complete
Unlock access to complete
Funding Insights of Akonni
Akonni has successfully raised a total of $39.75M across 50 strategic funding rounds. The most recent funding activity was a Grant round of $168.09 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Akonni
Akonni has secured backing from 6 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Ojp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Righton is associated with a brand presence online.
|
Locked | Locked | Locked |
Investor details for Akonni
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Akonni
Investment portfolio details for Akonni
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Akonni
Detailed financials for Akonni
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Akonni Comparisons
Peer comparison for Akonni
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Akonni
Akonni operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Somalogic, Nautilus Biotechnology, Inflammatix, Amunix and Visby Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Protein-based assays are developed for life science research.
|
|
| Locked | Locked | Locked |
A proteomics platform is developed for analyzing the human proteome.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
Detailed competitors of Akonni
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Akonni
Complete news archive for Akonni
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akonni
Akonni was founded in 2003.
Akonni is headquartered in Frederick, United States. It is registered at Frederick, Maryland, United States.
Akonni is a funded company, having raised a total of $39.75M across 50 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Akonni is 12.
Akonni Biosystem was founded in 2003 in Frederick, United States, and operates in the molecular diagnostics sector. Integrated systems for detecting complex infectious diseases, such as Methicillin-resistant Staphylococcus aureus, multi-drug-resistant tuberculosis, and oseltamivir-resistant influenza, are manufactured and marketed. The gel-drop microarray platform is utilized, with diagnostic tests and transportable readers provided for point-of-care applications in human health.
Akonni's top competitors include Somalogic, Visby Medical and Inflammatix.
Akonni offers TruTip Nucleic Acid Universal Kit, TruPrepR Automated Sample Preparation System, and TruDiagnosis.
Akonni has 6 investors. Key investors include NIH, HHS, Ojp, Righton, and National Science Foundation.